Status:
COMPLETED
Characteristics of Adult Patients With Recessive Dystrophic Epidermolysis Bullosa
Lead Sponsor:
Stanford University
Conditions:
Epidermolysis Bullosa Dystrophica
Eligibility:
All Genders
18+ years
Brief Summary
Recessive dystrophic epidermolysis bullosa (RDEB) is a severe inherited blistering disease caused by the absence of type VII collagen. Patients with RDEB develop large, severely painful blisters and o...
Eligibility Criteria
Inclusion
- Clinical diagnosis of RDEB by local dermatologist. 2. 18 years of age or more and willing to give consent.
Exclusion
- Medical instability limiting ability to travel to Stanford University Medical Center.
Key Trial Info
Start Date :
April 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2014
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT00904163
Start Date
April 1 2009
End Date
May 1 2014
Last Update
May 16 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University School of Medicine
Stanford, California, United States, 94305